| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/19/2009 | US7534875 Compositions for glioma classification |
| 05/19/2009 | US7534873 Method and materials for quaternary amine catalyzed bisulfite conversion of cytosine to uracil |
| 05/19/2009 | US7534872 9-fluorenylmethoxycarbonyl group (FMOC) for solid phase synthesis on optic glass filters; genetic engineering |
| 05/19/2009 | US7534869 Small and intermediate conductance, calcium-activated potassium channels and uses thereof |
| 05/19/2009 | US7534866 Methods and compositions for generating bioactive assemblies of increased complexity and uses |
| 05/19/2009 | US7534865 Bt toxin receptors from lepidopteran insects |
| 05/19/2009 | US7534864 Bt toxin receptors from lepidopteran insects |
| 05/19/2009 | US7534856 PRO19624 antibodies |
| 05/19/2009 | US7534772 Methods for enhancing antibody-induced cell lysis and treating cancer |
| 05/19/2009 | US7534646 Method of fabricating an organic field transistor |
| 05/19/2009 | US7534621 Method of producing probe medium and method of immobilizing probe using probe medium |
| 05/19/2009 | US7534620 Blood is drawn through a passageway, such as a catheter, past or against an obstruction or irregularity in the passageway, such as a wire placed in the catheter; platelets adhere and aggregate on the obstruction or on the wall of the passageway near the obstruction or irregularity, form a platelet mass |
| 05/19/2009 | US7534597 Fermenting lactic acid in kluyveromyces for use in cosmetics, pharmaceuticals, plastics and food production |
| 05/19/2009 | US7534596 Method and device for producing vaccine |
| 05/19/2009 | US7534587 Microsatellite markers for plants of the genus Triticeae and use thereof |
| 05/19/2009 | US7534584 Modular compositing-multiple lot screening protocols for detection of pathogens, microbial contaminants and/or constituents |
| 05/19/2009 | US7534583 Analyte measurement |
| 05/19/2009 | US7534582 Method for measuring the amount of natriuretic peptides in a sample |
| 05/19/2009 | US7534581 mixing and reacting gamma -thiobutyrolactone and the sample in the presence of a cholinesterase inhibitor ( physostigmine) and measuring 4-mercaptobutyric acid product produced using a thiol group detection reagent (5,5'-dithiobis(2-nitrobenzoic acid), 4,4'-bis(dimethylamino)benzhidrol etc.) |
| 05/19/2009 | US7534577 Functional assays that use the T1R2 taste receptor to identify potential taste modulators |
| 05/19/2009 | US7534576 Method and a device for the evaluation of biopolymer fitness |
| 05/19/2009 | US7534575 Method for detecting cancer using an antibody to Zcytor16 |
| 05/19/2009 | US7534574 Epitope-captured antibody display |
| 05/19/2009 | US7534573 comprising transfecting said neurons with a nucleic acid encoding a protein that is targeted to synaptic vesicles and that fluoresces when synaptic vesicles undergo exocytosis; for use in treating epilepsy and other brain disorders |
| 05/19/2009 | US7534571 ligand (referred to herein as "TREM-1-Ligand") of a myeloid cell receptor called TREM-1 (referred to herein as "TREM-1-Receptor") is a specific marker for bacterial and fungal sepsis |
| 05/19/2009 | US7534570 Method for the detection of cytosine methylations in immobilized DNA samples |
| 05/19/2009 | US7534569 using a polymerase extension reaction; elongation of an initial polynucleotide along a template oligonucleotide which has a 3' portion complementary to a 3' portion of the initial polynucleotide; template oligonucleotide can comprise a 3'-terminal blocker to prevent extension of the template |
| 05/19/2009 | US7534568 Polymerase, cleavage agent, upstream primer and downstream cleavage resistant probe; kits; incubation, hybridization, cleavage and fluorescent signal measurement |
| 05/19/2009 | US7534567 permits the identification of small sequence differences (e.g., sequence divergence of 1% or less) in nucleic acid samples of high complexity (e.g., an entire genome) |
| 05/19/2009 | US7534566 Nucleic acid labeling method and liquid composition |
| 05/19/2009 | US7534565 Using decreased expression of deleted in liver cancer 1(DLC-1) as diagnostic indicator of cell proliferative disorders in breast, collon and liver |
| 05/19/2009 | US7534564 Methods and compositions for polypeptide engineering |
| 05/19/2009 | US7534563 Methods for producing ligand arrays |
| 05/19/2009 | US7534562 Tetrahydrofolate synthetase gene |
| 05/19/2009 | US7534561 Nucleic acid array in situ fabrication methods and arrays produced using the same |
| 05/19/2009 | US7534560 Simple catalytic DNA biosensors for ions based on color changes |
| 05/19/2009 | US7534558 In vitro diagnostic test for enterovirus infections |
| 05/19/2009 | US7534445 isolated nucleotide sequences and degenerate sequences encoding the high molecular weight HMW protein; vaccines; antibodies; vectors |
| 05/19/2009 | US7534439 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses |
| 05/19/2009 | US7534432 Suppressing acitivity to treat musculodegenerative disease |
| 05/19/2009 | US7534428 Antibodies to tumor necrosis factor receptors 6α and 6β |
| 05/19/2009 | US7534426 Glutenase enzyme assays |
| 05/19/2009 | US7534425 As well as Paget's disease, neurological/neuromuscular diseases, nerve diseases, and/or psychotropic diseases; chloride channel modulators |
| 05/19/2009 | US7534419 Calibration using chaperone protein |
| 05/19/2009 | US7534417 Nucleotide sequences coding 103P2D6-related protein for diagnosing various tumors; anticarcinogenic agents; genetic vaccines |
| 05/19/2009 | US7534331 Use of microfluidic systems in the electrochemical detection of target analytes |
| 05/19/2009 | US7534330 Epoxy enhanced polymer membrane to increase durability of biosensors |
| 05/19/2009 | CA2611072A1 Novel compounds and uses thereof |
| 05/19/2009 | CA2495529C Noonan syndrome gene |
| 05/19/2009 | CA2400966C Rat model with the onset of prostate cancer |
| 05/19/2009 | CA2367955C Abc1 polypeptide and methods and reagents for modulating cholesterol levels |
| 05/19/2009 | CA2353546C Diagnosis of stage or aggressiveness of cancer |
| 05/19/2009 | CA2274620C Microfabricated sleeve devices for chemical reactions |
| 05/19/2009 | CA2247071C Dna vaccination for induction of suppressive t cell response |
| 05/19/2009 | CA2181131C Chemiluminescent analytical method |
| 05/19/2009 | CA2032203C Amplification capture assay |
| 05/14/2009 | WO2009062199A1 EGFR/NEDD9/TGF-β LNTERACTOME AND METHODS OF USE THEREOF FOR THE IDENTIFICATION OF AGENTS HAVING EFFICACY IN THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS |
| 05/14/2009 | WO2009062170A1 Molecular affinity clamp technology and uses thereof |
| 05/14/2009 | WO2009062166A2 Dna microarray based identification and mapping of balanced translocation breakpoints |
| 05/14/2009 | WO2009062125A1 Methods and compositions for assessing responsiveness of b-cell lymphoma to treatment with anti-cd40 antibodies |
| 05/14/2009 | WO2009062099A1 Electrochemical system and method thereof |
| 05/14/2009 | WO2009062083A2 Methods and compositions for antibody therapy |
| 05/14/2009 | WO2009062081A2 Methods and compositions for antibody or vaccine therapy |
| 05/14/2009 | WO2009062080A1 Methods for doing business using biomarkers |
| 05/14/2009 | WO2009062078A1 Jak2 mutations |
| 05/14/2009 | WO2009062051A2 Methods and compositions for antibody therapy |
| 05/14/2009 | WO2009062042A2 Methods and compositions for improved cattle longevity and milk production |
| 05/14/2009 | WO2009062008A2 Methods and compositions for improved fertilization and embryonic survival |
| 05/14/2009 | WO2009061961A1 Use of vitamin d receptor agonists and precursors to treat fibrosis |
| 05/14/2009 | WO2009061941A2 Baseless nucleotide analogues and uses thereof |
| 05/14/2009 | WO2009061890A1 Methods and compositions for the diagnosis, prognosis and treatment of chronic myeloid leukemia and acute lymphoblastic leukemia |
| 05/14/2009 | WO2009061859A2 Protein crystal of human cytochrome p450 aromatase and uses thereof |
| 05/14/2009 | WO2009061843A2 Induced-charge electrokinetics with high-slip polarizable surfaces |
| 05/14/2009 | WO2009061800A2 Methods and compositions for diagnostic use in cancer patients |
| 05/14/2009 | WO2009061799A2 Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof |
| 05/14/2009 | WO2009061752A1 Methods for detecting toxigenic microbes |
| 05/14/2009 | WO2009061734A1 Identification of subjects likely to benefit from statin therapy |
| 05/14/2009 | WO2009061733A2 Novel plating media |
| 05/14/2009 | WO2009061697A1 Anticoagulant antagonist and hemophilia procoagulant |
| 05/14/2009 | WO2009061641A2 Automated analyzer for clinical laboratory |
| 05/14/2009 | WO2009061515A1 Self-assembling micelle-like nanoparticles for systemic gene delivery |
| 05/14/2009 | WO2009061506A2 Diagnostics for aging-related dermatologic disorders |
| 05/14/2009 | WO2009061413A2 Hybrid fusion reporter and uses thereof |
| 05/14/2009 | WO2009061412A1 Methods for detecting or monitoring cancer using lpe as a marker |
| 05/14/2009 | WO2009061393A1 Probe for measuring phytase activity |
| 05/14/2009 | WO2009061377A2 Detecting microorganisms in blood utilizing physical and chemical changes in blood |
| 05/14/2009 | WO2009061369A2 Directed evolution using proteins comprising unnatural amino acids |
| 05/14/2009 | WO2009061297A1 Gene expression profiling for identification of cancer |
| 05/14/2009 | WO2009060847A1 Method and kit for preparation of sample for use in nucleic acid amplification |
| 05/14/2009 | WO2009060804A1 Mutant nucleic acid associated with chronic myeloproliferative disorder, and method for evaluation of chronic myeloproliferative disorder |
| 05/14/2009 | WO2009060316A2 Hepatitis b virus-binding polypeptides and methods of use thereof |
| 05/14/2009 | WO2009060217A2 Streptococcus pyogenes classification |
| 05/14/2009 | WO2009060210A2 Predictive test for adult dog body size |
| 05/14/2009 | WO2009060124A2 Use of oligonucleotides with modified bases in hybridization of nucleic acids |
| 05/14/2009 | WO2009060101A1 Dusp4 as clinically relevant epigenetic marker and therapeutic target in gliomas and other tumors |
| 05/14/2009 | WO2009060089A1 Method of diagnosis and subgroup analysis in subjects having or being suspected of having irritable bowel syndrome, nucleic acids and kits, and their use |
| 05/14/2009 | WO2009060066A1 A method for predicting the therapeutic responsiveness of patients to a medical treatment with an interferon |
| 05/14/2009 | WO2009060035A1 Gene expression signatures for chronic/sclerosing allograft nephropathy |
| 05/14/2009 | WO2009059784A1 Biocompatible three dimensional matrix for the immobilization of biological substances |
| 05/14/2009 | WO2009059777A1 New cucumber plants with a compact growing habit |